Jarrod S. Johnson

1.3k total citations
20 papers, 962 citations indexed

About

Jarrod S. Johnson is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, Jarrod S. Johnson has authored 20 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Virology and 6 papers in Immunology. Recurrent topics in Jarrod S. Johnson's work include HIV Research and Treatment (6 papers), Virus-based gene therapy research (5 papers) and interferon and immune responses (3 papers). Jarrod S. Johnson is often cited by papers focused on HIV Research and Treatment (6 papers), Virus-based gene therapy research (5 papers) and interferon and immune responses (3 papers). Jarrod S. Johnson collaborates with scholars based in United States, France and China. Jarrod S. Johnson's co-authors include R. Jude Samulski, Mavis Agbandje‐McKenna, Nina DiPrimio, Thomas J. McCown, Devin E. Christensen, Wesley I. Sundquist, Owen Pornillos, Wuping Li, Barbie K. Ganser‐Pornillos and Aravind Asokan and has published in prestigious journals such as Science, Journal of Virology and Cell Death and Differentiation.

In The Last Decade

Jarrod S. Johnson

19 papers receiving 952 citations

Peers

Jarrod S. Johnson
Bruce C. Schnepp United States
Oya Cingöz United States
Michael A. DiMattia United States
Ashley I. Beyer United States
T Friedmann United States
Jonathan Diep United States
Chong-Yun Xiao Australia
Christopher S. Barker United States
Jarrod S. Johnson
Citations per year, relative to Jarrod S. Johnson Jarrod S. Johnson (= 1×) peers Hongxing Zhao

Countries citing papers authored by Jarrod S. Johnson

Since Specialization
Citations

This map shows the geographic impact of Jarrod S. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarrod S. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarrod S. Johnson more than expected).

Fields of papers citing papers by Jarrod S. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarrod S. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarrod S. Johnson. The network helps show where Jarrod S. Johnson may publish in the future.

Co-authorship network of co-authors of Jarrod S. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Jarrod S. Johnson. A scholar is included among the top collaborators of Jarrod S. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarrod S. Johnson. Jarrod S. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christensen, Devin E., Miguel J. B. Pereira, Wen Zhou, et al.. (2025). Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing. PLoS Pathogens. 21(1). e1012206–e1012206. 4 indexed citations
2.
Pradeep, Soorya, Sandra D. Scherer, Defne Bayık, et al.. (2023). Transferred mitochondria accumulate reactive oxygen species, promoting proliferation. eLife. 12. 53 indexed citations
3.
Vijayan, Kamalakannan, Nadia Arang, Ling Wei, et al.. (2022). A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection. Cell chemical biology. 29(9). 1419–1433.e5. 12 indexed citations
4.
Olson, Gregory S., et al.. (2022). Genetic Modification of Primary Human Myeloid Cells to Study Cell Migration, Activation, and Organelle Dynamics. Current Protocols. 2(8). e514–e514. 3 indexed citations
5.
Johnson, Jarrod S., Alexander Rives, Xavier Lahaye, et al.. (2020). A Comprehensive Map of the Monocyte-Derived Dendritic Cell Transcriptional Network Engaged upon Innate Sensing of HIV. Cell Reports. 30(3). 914–931.e9. 18 indexed citations
6.
Drouin, Lauren M., Zhijian Wu, R. Jude Samulski, et al.. (2020). Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium. UNC Libraries. 1 indexed citations
7.
Christensen, Devin E., Barbie K. Ganser‐Pornillos, Jarrod S. Johnson, Owen Pornillos, & Wesley I. Sundquist. (2020). Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro. Science. 370(6513). 106 indexed citations
8.
Samulski, R. Jude, Stefan W. Leichtle, Mavis Agbandje‐McKenna, et al.. (2020). Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles. UNC Libraries.
9.
Kain, Heather S., Elizabeth K. K. Glennon, Kamalakannan Vijayan, et al.. (2019). Liver stage malaria infection is controlled by host regulators of lipid peroxidation. Cell Death and Differentiation. 27(1). 44–54. 69 indexed citations
10.
Johnson, Jarrod S., Lynn M. Amon, Sara Carbonetti, et al.. (2018). Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection. Cell Host & Microbe. 23(3). 366–381.e9. 27 indexed citations
11.
Johnson, Jarrod S., Martina Gentzsch, Liqun Zhang, et al.. (2011). AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis. PLoS Pathogens. 7(5). e1002053–e1002053. 37 indexed citations
12.
Johnson, Jarrod S., Chengwen Li, Nina DiPrimio, et al.. (2010). Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific Transduction. Journal of Virology. 84(17). 8888–8902. 80 indexed citations
13.
Li, Wuping, Liqun Zhang, Jarrod S. Johnson, et al.. (2009). Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium. Molecular Therapy. 17(12). 2067–2077. 67 indexed citations
14.
Asokan, Aravind, et al.. (2008). Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals. Gene Therapy. 15(24). 1618–1622. 26 indexed citations
15.
Li, Wuping, Aravind Asokan, Zhijian Wu, et al.. (2008). Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles. Molecular Therapy. 16(7). 1252–1260. 201 indexed citations
16.
Johnson, Jarrod S. & R. Jude Samulski. (2008). Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus. Journal of Virology. 83(6). 2632–2644. 116 indexed citations
17.
Grieger, Joshua C., Jarrod S. Johnson, Brittney L. Gurda, Mavis Agbandje‐McKenna, & R. Jude Samulski. (2007). Surface-Exposed Adeno-Associated Virus Vp1-NLS Capsid Fusion Protein Rescues Infectivity of Noninfectious Wild-Type Vp2/Vp3 and Vp3-Only Capsids but Not That of Fivefold Pore Mutant Virions. Journal of Virology. 81(15). 7833–7843. 65 indexed citations
18.
Johnson, Jarrod S., Kyle J. Roux, Bradley S. Fletcher, Jenny Fortun, & Lucia Notterpek. (2005). Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: Implications for neuropathy severity. Journal of Neuroscience Research. 82(6). 743–752. 9 indexed citations
19.
Byrn, Randal A., Iwao Sekigawa, Steven M. Chamow, et al.. (1989). Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. Journal of Virology. 63(10). 4370–4375. 54 indexed citations
20.
Haase, Ashley T., Jarrod S. Johnson, J. A. Kasel, Simeón Margolis, & Hilton B. Levy. (1970). Induction of Interferon in Lymphoblastoid Cell Lines. Experimental Biology and Medicine. 133(3). 1076–1083. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026